JCI Editor’s update: November 2017

I am pleased to be providing this first ASCI member update on Journal activity since my tenure as Editor of the Journal of Clinical Investigation began on July 1. It is an honor for me, along with the distinguished JCI Editorial Board based at Johns Hopkins University, to serve the ASCI in publishing the best research across biomedicine.

A byword for the Board is flexibility, providing a venue for a variety of cutting-edge stories to be told. Starting November 1, authors will be able to publish in the JCI’s Concise Communication category, a flexible format for brief, elegant, and captivating scientific pieces. Submissions in this category, which replaces Brief Reports, have a higher word limit of 4,000 and more liberal treatment of display items. I encourage you to use this category to submit your definitive but short-form papers. For details, see my recent Editorial.

In its Research and Clinical Medicine categories, the JCI continues to be a home to full-story science. The recommended length for these submissions is 9,000 words (maximum 12,000). JCI submission types are described in detail here.

ASCI members are, as ever, a mainstay of the JCI. We are fortunate to have Society members well represented on the Board. Deputy Editors Rexford Ahima and Arturo Casadevall, as well as the majority of Associate Editors, are members of the ASCI. We are also fortunate to have many members serving on our expert team of Consulting Editors.

Highlighted below are recent articles with ASCI members as corresponding authors, in a wide range of specialties, such as neuroscience, oncology, immunology, hematology, and metabolism. I’d also like to take this opportunity to remind you that any current ASCI member who is a corresponding author of a first-round submission to the JCI may designate one submission per calendar year to be guaranteed for external peer review. See Information for authors for details on submitting a manuscript.

Thank you, as always, for your interest in the JCI.

Gordon F. Tomaselli, MD
Editor, The Journal of Clinical Investigation

ASCI members in the JCI

The following articles published in recent months have corresponding authors who are ASCI members (in bold):

















The Journal of Clinical Investigation (JCI) is a premier venue for discoveries in basic and clinical biomedical science that will advance the practice of medicine. The JCI publishes across all medical specialties and provides public access, without subscription, to all research it publishes. Founded in 1924, the JCI is published by the American Society for Clinical Investigation, a nonprofit honor society of physician-scientists. The JCI’s 2016 Impact Factor is 12.784.